Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Eiwegger

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
The European Respiratory Journal|June 6, 2024
European Respiratory Society statement on preschool wheezing disorders: updated definitions, knowledge gaps and proposed future research directionsHeidi Makrinioti, Valentina Fainardi, Klaus Bonnelykke, et al.
ERJ Open Research|November 23, 2017
<i>Aspergillus fumigatus</i>-specific immunoglobulin levels in BALF of CF patientsMia Goña-Höpler, Birgit Pfaller, Jonathan Argeny, et al.
The Journal of Allergy and Clinical Immunology|February 17, 2012
Inhibition of angiogenesis by IL-32: possible role in asthmaNorbert Meyer, Janine Christoph, Heidi Makrinioti, et al.
The Journal of Allergy and Clinical Immunology|February 4, 2014
The expression of cannabinoid receptor 1 is significantly increased in atopic patientsMar Martín-Fontecha, Thomas Eiwegger, Tuomas Jartti, et al.
Allergy|May 7, 2019
Future research trends in understanding the mechanisms underlying allergic diseases for improved patient careHeimo Breiteneder, Zuzana Diamant, Thomas Eiwegger, et al.
Allergy|September 28, 2024
Clinical utility analysis of the Hoxb8 mast cell activation test for the diagnosis of peanut allergyNoemi Bachmeier-Zbären, Alper Celik, Robin van Brummelen, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 2, 2020
Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapyAlexandra Langlois, Marie-Hélène Lavergne, Hélène Leroux, et al.
Allergy|January 16, 2021
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccinesMilena Sokolowska, Thomas Eiwegger, Markus Ollert, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 30, 2023
Identification of motivators and barriers impacting successful food introduction or reintroduction after negative oral food challengesChristina M Ditlof, Roxanne H Hummel, Sam Wong, et al.
Allergy|February 5, 2026
Updated Treatment of Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease: How to Decide on Aspirin Therapy After Desensitization or Biologics? When? How? An EAACI Task Force ReportGülfem E Çelik, Joanna S Makowska, Maria Jose Torres, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
The European Respiratory Journal|June 6, 2024
European Respiratory Society statement on preschool wheezing disorders: updated definitions, knowledge gaps and proposed future research directionsHeidi Makrinioti, Valentina Fainardi, Klaus Bonnelykke, et al.
ERJ Open Research|November 23, 2017
<i>Aspergillus fumigatus</i>-specific immunoglobulin levels in BALF of CF patientsMia Goña-Höpler, Birgit Pfaller, Jonathan Argeny, et al.
The Journal of Allergy and Clinical Immunology|February 17, 2012
Inhibition of angiogenesis by IL-32: possible role in asthmaNorbert Meyer, Janine Christoph, Heidi Makrinioti, et al.
The Journal of Allergy and Clinical Immunology|February 4, 2014
The expression of cannabinoid receptor 1 is significantly increased in atopic patientsMar Martín-Fontecha, Thomas Eiwegger, Tuomas Jartti, et al.
Allergy|May 7, 2019
Future research trends in understanding the mechanisms underlying allergic diseases for improved patient careHeimo Breiteneder, Zuzana Diamant, Thomas Eiwegger, et al.
Allergy|September 28, 2024
Clinical utility analysis of the Hoxb8 mast cell activation test for the diagnosis of peanut allergyNoemi Bachmeier-Zbären, Alper Celik, Robin van Brummelen, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 2, 2020
Correction to: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapyAlexandra Langlois, Marie-Hélène Lavergne, Hélène Leroux, et al.
Allergy|January 16, 2021
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccinesMilena Sokolowska, Thomas Eiwegger, Markus Ollert, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 30, 2023
Identification of motivators and barriers impacting successful food introduction or reintroduction after negative oral food challengesChristina M Ditlof, Roxanne H Hummel, Sam Wong, et al.
Allergy|February 5, 2026
Updated Treatment of Non-Steroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease: How to Decide on Aspirin Therapy After Desensitization or Biologics? When? How? An EAACI Task Force ReportGülfem E Çelik, Joanna S Makowska, Maria Jose Torres, et al.
Pageof 13